Dikshit Rajesh P, Nagrani Rajini, Yeole Balkrishna, Koyande Shravani, Banawali Shripad
Department of Epidemiology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Indian J Med Paediatr Oncol. 2011 Apr;32(2):96-100. doi: 10.4103/0971-5851.89792.
Little is known about burden of chronic myeloid leukemia (CML) in India. There is a recent interest to observe incidence and mortality because of advent of new diagnostic and treatment policies for CML.
We extracted data from the oldest population-based cancer registry of Mumbai for 30 years period from 1976-2005 to observe incidence and mortality rates of CML. We classified the data into four age groups 0-14, 15-29, 30-54 and 55-74 to observe incidence rates in the respective age groups.
The age specific rates were highest for the age group of 55-74 years. No significant change in trends of CML was observed for 30 years period. However, there was a significant reduction in incidence rate for recent 15-years period (Estimated average annual percentage change=-3.9). No significant reduction in mortality rate was observed till 2005.
The study demonstrates that age-specific rates for CML are highest in age group of 55-74 years, although they are lower compared to western populations. Significant reduction in incidence of CML in recent periods might be because of reduced misclassification of leukemias. The data of CML has to be observed for another decade to witness reduction in mortality because of changes in treatment management.
在印度,关于慢性髓性白血病(CML)的负担了解甚少。由于CML新的诊断和治疗政策的出现,最近人们对观察其发病率和死亡率产生了兴趣。
我们从孟买最古老的基于人群的癌症登记处提取了1976年至2005年30年间的数据,以观察CML的发病率和死亡率。我们将数据分为四个年龄组:0 - 14岁、15 - 29岁、30 - 54岁和55 - 74岁,以观察各年龄组的发病率。
55 - 74岁年龄组的年龄别发病率最高。在30年期间,未观察到CML趋势的显著变化。然而,在最近15年期间发病率有显著下降(估计平均年百分比变化 = -3.9)。直到2005年,死亡率没有显著下降。
该研究表明,CML的年龄别发病率在55 - 74岁年龄组最高,尽管与西方人群相比更低。近期CML发病率的显著下降可能是由于白血病误诊率降低。由于治疗管理的变化,CML的数据还需再观察十年才能看到死亡率的下降。